weight loss

arrow back backwards u-turn turn around reverse
Biotech

Ascletis slashes funds for former core programs in obesity pivot

Ascletis is increasing investment in obesity while retreating from antiviral, oncology and liver programs that were once at the heart of its strategy.
Nick Paul Taylor Mar 26, 2025 10:00am
MA strategy deal block push come together form

Mira seeks to buy Skny for obesity, smoking cessation asset

Mar 24, 2025 10:08am
boat cutting through water

Amgen’s late-stage obesity trials expected to read out in ‘27

Mar 5, 2025 1:58pm
obesity overweight weight loss weigh

Kallyope links oral obesity combo to 3% weight loss at Week 13

Feb 27, 2025 10:17am
pipelines in the sun

Lilly's next focus: Testing incretins in neuro, immunology fields

Feb 6, 2025 2:35pm
weight loss scale weigh measure tape obesity overweight

Versant launches another obesity biotech with $65M series A

Jan 28, 2025 8:35am